These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Current data on salicylates].
    Author: Griton P.
    Journal: Phlebologie; 1978; 31(2):89-92. PubMed ID: 693603.
    Abstract:
    The best-known among the sclerosing products, sodium salicylate, should still be the most commonly used. It gives a large and reliable sclerosis with a flexible posology and a large margin of safety. The injection cramp may be relieved by adding to the concentrated product 60% of an equal amount of 2% Xylocaine. Practically speaking, the weakness of the sclerosing capacity necessitates, for large arches, the use of more powerful drugs. Salicylate, however, can completely sclerose 2 internal saphenous veins out of 10, and 3 external saphenous veins out of 10. After reduction of the long reflux, salicylate seems today to be the best product to use in all varicose vein cases.
    [Abstract] [Full Text] [Related] [New Search]